Abstract:The Vero cell is the continuous cell line used as a cell substrate for many viral vaccines manufacturing including Rabies vaccine. The Pitman and PV-11 strains of rabies virus are commonly used for production of rabies vaccines. In our study the PV - 11 strain is used as seed virus for the production of Vero cell derived inactivated Anti Rabies Vaccines (Lyophilized). The working cell bank and working virus seed lot were prepared and tested for its sterility and mycoplasma contamination. In this study the roller bottle method and micro carrier (cytodex-1) based bioreactor culturing method were standardized with MEM Eagles and RPMI 1640 medium. The outcome of the two methods were compared ,to find out the medium and culturing method which can give higher concentration of Vero cells to get higher viral titre in mass production. The quantities of Vero cells obtained from passage 144 to 148 were assessed using a haemocytometer cell count procedure. The quantity of the Vero cell obtained per roller bottle ranged from 222.82x106 cells to 236.67x106 cells in MEM Eagles medium and 227.80x106 cells to 230.66x106 cells in RPMI 1640 medium. The average quantity of Vero cells in roller bottles were 1.12 x 106 cells per ml of culture. In the bioreactor culturing method the Vero cells obtained in the concentration of 1.69 to 1.75 million cells / ml of culture by MEM Eagles medium and 1.67 to 1.70 million cells / ml by RPMI 1640 medium. In the bioreactor the average yield of vero cells ranged 1.70 x106 cells per ml of culture. It is estimated that about 35% increase in Vero cell quantity in bioreactor system than the roller bottle culturing method. 0.3 MOI (Multiplicity of Infection) of rabies virus was kept as constant for infection of confluent monolayered Vero cells in both roller bottle and bioreactor culture. Four viral harvests were collected at three day intervals and replenished with fresh culturing medium each time. The viral titres in each viral harvest were quantified using in-house standardized RT-PCR method; the roller bottle method yielded viral titre log 6.044 to 7.106 and the bioreactor culture yielded log 6.559 to 7.216 rabies viral particles. It is observed that the bioreactor culture yielded more viral titre than the roller bottle culture using both the medium.

BHK -21 Cell Grown on Microcarrier System Increasing The Capacity of Rabies Vaccine

Optimization of Virus Yield as a Strategy to Increase the Efficiency of Rabies Vaccine by BHK-21 Cells in a Bioreactor

Cell Surface Display of Rabies Virus Glycoprotein by Using Ice Nucleation Protein

Application prospects of the 2BS cell-adapted China fixed rabies virus vaccine strain 2aG4-B40

Standardization of microcarrier based bioreactor culture in parallel with roller bottle for rabies virus (PV-11) propagation in Vero cell using MEM eagle’s and RPMI 1640 medium

Pre-marketing immunogenicity and safety of a lyophilized purified human diploid cell rabies vaccine produced from microcarrier cultures: a randomized clinical trial

Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach

A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein

Study on Preparation of New Purified Vero Cell Rabies Vaccine

Virus production with a newly developed microcarrier system

A Novel Scale-Up Strategy for Cultivation of BHK-21 Cells Based on Similar Hydrodynamic Environments in the Bioreactors.

Advances on Rabies Vaccines

Pseudorabies virus production using a serum-free medium in fixed-bed bioreactors with low cell inoculum density

A Study on Scale-up Process for Microcarrier Cultue of MDCK Cells Using Low Serum Medium

Preliminary Optimization of Production Condition of Rabies Virus with MDCKCells Cultured in Serum-free Medium

Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells

Efficiency Comparative Approach of Plant-Produced Monoclonal Antibodies against Rabies Virus Infection

Expanding virus susceptibility spectrum of MDBK cells by expressing host receptors nectin 4 and TfR

Construction of Vero cell-adapted rabies vaccine strain by five amino acid substitutions in HEP-Flury strain

Production, purification, and characterization of recombinant rabies virus glycoprotein expressed in PichiaPink™ yeast